| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 37 |
| 1 | BEVACIZUMAB | 34 |
| 2 | MITOMYCIN | 34 |
| 3 | LEVONORGESTREL | 28 |
| 4 | ACETAMINOPHEN | 16 |
| 5 | OMEPRAZOLE MAGNESIUM | 15 |
| 6 | ACETAMINOPHEN 500MG | 13 |
| 7 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 13 |
| 8 | CISPLATIN | 13 |
| 9 | PAIN RELIEVER | 13 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CITRIC ACID, GLUCONOLACTONE AND MAGNESIUM CARBONATE | 1 | 0.0588 |
| 1 | HYOSCYAMINE SULFATE, METHENAMINE, METHYLENE BLUE, PHENYL SALICYLATE, AND SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE | 1 | 0.0111 |
| 2 | MITOMYCIN | 34 | 0.0093 |
| 3 | NALDEMEDINE | 3 | 0.0018 |
| 4 | MEPIVACAINE HYDROCHLORIDE | 2 | 0.0017 |
| 5 | PROMETHAZINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE | 1 | 0.0016 |
| 6 | CHLOROQUINE PHOSPHATE | 1 | 0.0015 |
| 7 | CUPRIC CHLORIDE | 1 | 0.0013 |
| 8 | AMINOCAPROIC ACID | 1 | 0.0012 |
| 9 | TOPICAL ANESTHETIC | 1 | 0.0012 |
| # | Drug class | Count |
|---|---|---|
| 0 | Alkylating Drug [EPC] | 40 |
| 1 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 34 |
| 2 | Corticosteroid [EPC] | 32 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 29 |
| 4 | Progestin [EPC] | 29 |
| 5 | Progestin-containing Intrauterine System [EPC] | 28 |
| 6 | Benzodiazepine [EPC] | 24 |
| 7 | Platinum-based Drug [EPC] | 24 |
| 8 | Proton Pump Inhibitor [EPC] | 19 |
| 9 | Nucleoside Metabolic Inhibitor [EPC] | 18 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC] | 2 | 0.0011 |
| 1 | Antifibrinolytic Agent [EPC] | 5 | 0.0005 |
| 2 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 3 | Blood Viscosity Reducer [EPC] | 2 | 0.0005 |
| 4 | alpha-1 Adrenergic Agonist [EPC] | 2 | 0.0005 |
| 5 | Semifluorinated Alkane [EPC] | 1 | 0.0004 |
| 6 | Oxytocic [EPC] | 1 | 0.0003 |
| 7 | Provitamin D2 Compound [EPC] | 8 | 0.0003 |
| 8 | Anti-coagulant [EPC] | 1 | 0.0003 |
| 9 | Neonatal Fc Receptor Blocker [EPC] | 1 | 0.0002 |